INVEST Drug Abuse Research Fellowship
The National Institute on Drug Abuse (NIDA) International Progam INVEST Drug Abuse Research Fellowship combines postdoctoral research training in the United States with professional development activities and grant-writing guidance to form a unique program for drug abuse scientists. Fellows may conduct their research in any aspect of the biomedical or behavioral science of drug abuse and addiction. Previous fellows have conducted research in all aspects of drug abuse and addiction, from social science to basic science, including epidemiology, prevention, treatment, and preclinical and clinical sciences. Fellows and their mentors are encouraged to develop jointly and seek funding for a collaborative research project to be conducted in the fellow's home country. Fellows and their U.S. mentors are part of a network of international scientists who exchange information and collaborate on drug abuse research nationally, regionally, and globally.
What Does the Fellowship Include?
The 12-month fellowship provides:
- Rigorous postdoctoral research training with a NIDA grantee at a U.S. institution.
- Professional development activities that help you establish personal relationships with NIDA grantees and NIDA officials who are willing to continue working with you after you return home.
- A stipend of $39,000US for living and personal expenses, round-trip travel, and a $6,000US allowance to cover the cost of health insurance and professional development activities.
Who Is Eligible?
The requirements for INVEST applicants are:
- An earned doctoral degree in medicine, public health, or biomedical, behavioral, or social sciences.
- A minimum of 2 years of postdoctoral research experience, including a demonstrated ability to engage in independent research.
- Written assurance from an institution in the home country that there is a position to which the applicant can return after completing the fellowship.
- Proficiency in written and spoken English.
- Citizenship or permanent residency in a country other than the United States.
- Living and working outside the United States at the time the application is submitted.
- Eligibility for the J-1 visa to enter the United States.
How Should I Apply?
The INVEST Drug Abuse Research Fellowship application requires careful and thorough coordination between the applicant and mentor:
- Contact a NIDA-supported researcher in the United States who is willing to serve as a mentor. The mentor must be a current NIDA grantee.
- Notify the NIDA International Program of your plans to apply.
- Write a detailed research plan for working with the U.S. mentor on biomedical or behavioral research investigating the causes, consequences, prevention, or treatment of drug abuse and addiction.
- Complete and submit your application to the NIDA International Program.
How Can I Get Help in Finding a Mentor?
To find the mentor who is right for you, consult the online database of research projects supported by the National Institutes of Health (NIH) at http://projectreporter.nih.gov/reporter.cfm, review journals online at PubMed at http://www.ncbi.nlm.nih.gov/pubmed/, or email the NIDA International Program for assistance at ip@nida.nih.gov.
Application Deadlines: April 1
Notification of Award: June 1
What Materials Should I Use To Apply?
Instruction and application materials for the INVEST Drug Abuse Research Fellowship can be downloaded from this Web site in Microsoft Word and Adobe PDF format.
-
INVEST Drug Abuse Research Fellowship Instruction Packet
PDF Format (84KB)
MS Word Format (142KB) -
INVEST Drug Abuse Research Fellowship Application Packet
PDF Format (132KB)
MS Word Format (319KB)
Who Has Been an INVEST Drug Abuse Research Fellow and Mentor?
Year | Fellow | Mentor |
---|---|---|
2010-2011 |
Gabor Egervari Hungary |
Yasmin L. Hurd, Ph.D. Mount Sinai School of Medicine |
Saeed Momtazi Iran |
Richard A. Rawson, Ph.D. University of California, Los Angeles |
|
Arina Tyurina Russia |
Jeffrey H. Samet, M.D., M.P.H. Boston Medical Center |
|
2009-2010 |
Perrine Roux France |
Sandra Comer, Ph.D. Columbia University |
Mikhail Torban Russia |
Robert Heimer, Ph.D. Yale University |
|
Huaihui Zhang China |
Richard Schottenfeld, M.D. Yale University |
|
2008-2009 |
Marta Concheiro Guisan Spain |
Marilyn Huestis, Ph.D. NIDA Intramural Research Program |
Sheng Liu China |
Gary S. Aston-Jones, Ph.D. Medical University of South Carolina |
|
Alberto Moriggia Italy |
David L. Thomas, M.D. Johns Hopkins University School of Medicine |
|
2007-2008 |
Jiang Du China |
Hser Yih-Ing, Ph.D. University of California, Los Angeles |
Paula M. Mayock Ireland |
Michael C. Clatts, Ph.D. National Development and Research Institutes, Inc. |
|
Adhi Wibowo Nurhidayat Indonesia |
David Metzger, Ph.D., and George E. Woody, M.D. University of Pennsylvania |
|
Akiko Shimamoto Kiyoshima Japan |
Klaus A. Miczek, Ph.D. Tufts University |
|
Paulo Roberto Telles P. Diaz Brazil |
Kimberly Page Shafer, Ph.D. Institute for Global Health/CAPS, University of California, San Francisco |
|
Wenhua Zhou China |
Peter Kalivas, Ph.D. Medical University of South Carolina |
|
2006-2007 |
Wagner Alves de Souza Judice Brazil |
Iris Lindberg, Ph.D., M.P.H. Louisiana State University and the University of Maryland, Baltimore |
Doug Hyun Han South Korea |
Perry F. Renshaw, M.D., Ph.D. McLean Brain Imaging Center and Harvard Medical School |
|
Sung-Jin Cho South Korea |
Alan P. Kozikowski, Ph.D. University of Illinois at Chicago |
|
2005-2006 |
Tsafrir Loebl Israel |
A. Eden Evins, M.D., M.P.H. Addictions Research Program, Massachusetts General Hospital |
Oscar Quintela Spain |
Dennis Crouch, M.B.A. Center for Human Toxicology, University of Utah J. Michael Walsh, Ph.D. The Walsh Group |
|
Maciej Stasiak Poland |
Nicholas E. Goeders, Ph.D. Louisiana State University, Health Sciences Center - Shreveport |
|
Young Hoon Sung South Korea |
Perry F. Renshaw, M.D., Ph.D. McLean Brain Imaging Center |
|
2004-2005 |
Marco Bortolato Italy |
Daniele Piomelli, Ph.D., Pharm.D. University of California, Irvine |
Lan Zhang China |
Kenneth Kendler, M.D. Virginia Commonwealth University |
|
Liliana Cancela Argentina |
Peter W. Kalivas, Ph.D. Medical University of South Carolina |
|
2003-2004 |
Marjaterttu Pajulo Finland |
Linda C. Mayes, M.D. Yale University School of Medicine |
Yufeng Chen China |
Alan P. Kozikowski, Ph.D. University of Illinois at Chicago |
|
2002-2003 |
Isabelle Husson France |
Barry E. Kosofsky, M.D., Ph.D. Harvard Medical School and Massachusetts General Hospital East |
Tamo Nakamura Australia |
Anthony A. Wright, Ph.D. University of Texas Medical School at Houston |
|
Yilang Tang China |
Joseph F. Cubells, M.D., Ph.D. Yale University School of Medicine |
|
2001-2002 |
Debasish Basu India |
Joel Gelernter, M.D. Yale University |
Patricia Obando Costa Rica |
Dace Svikis, Ph.D. Virginia Commonwealth University |
|
Tatiana P. Tsarouk Russia |
Elaine Thompson, Ph.D. University of Washington, Seattle |
|
Min Zhao China |
Howard Liddle, Ed.D. University of Miami School of Medicine |
|
2000-2001 |
Henrik Druid Sweden |
Deborah C. Mash, Ph.D. University of Miami |
Chuang Liu China |
Elliot A. Stein, Ph.D. Medical College of Wisconsin, Milwaukee |
|
1999-2000 |
Abdel Azim Assi Egypt |
Charles I. Chavkin, Ph.D. University of Washington, Seattle |
Elisa Mengual Spain |
Virginia M. Pickel, Ph.D. Weill Medical College of Cornell University |
|
Vaughan Rees Australia |
Jeffrey H. Samet, M.D., M.P.H. Boston University School of Medicine |
|
1998-1999 |
You Wan China |
Jeffrey S. Mogil, Ph.D. University of Illinois at Urbana-Champaign |
Neo Morojele South Africa |
Judith S. Brook, Ed.D. Mount Sinai School of Medicine |
|
1997-1998 |
Guilherme Borges Mexico |
Ronald C. Kessler, Ph.D. Harvard Medical School |
Yulia Lyupina Russia |
James E. Smith, Ph.D. Wake Forest University School of Medicine |
|
Olivier Manzoni France |
John T. Williams, Ph.D. Oregon Health Sciences University |
|
1996-1997 |
Silvia Cruz Mexico |
Robert L. Balster, Ph.D. Virginia Commonwealth University School of Medicine |
Raka Jain India |
Stephen G. Holtzman, Ph.D. (deceased) Emory University School of Medicine |
|
Danxin Wang China |
Wolfgang Sadée, Ph.D. University of California, San Francisco |
|
1995-1996 |
Bashir Ahmad Pakistan |
Nissar A. Darmani, Ph.D. Kirksville College of Osteopathic Medicine |
Irena Martin-Kleiner Croatia |
Jean M. Bidlack, Ph.D. University of Rochester |
|
Steve McGaraughty Canada |
Mary M. Heinricher, Ph.D. Oregon Health Sciences University |
|
Zhengxiong Xi China |
Elliot A. Stein, Ph.D. Medical College of Wisconsin, Milwaukee |
|
1994-1995 |
Anton Bespalov Russia |
Robert L. Balster, Ph.D. Virginia Commonwealth University School of Medicine |
Suchandra Ghosh India |
Martin A. Adler, Ph.D. Temple University School of Medicine |
|
Ella Nikulina Russia |
Klaus A. Miczek, Ph.D. Tufts University |
|
1993-1994 |
Yaprak Egilmez Turkey |
Michael Emmett Oglesby, Ph.D. University of North Texas Health Science Center |
Gerald Zernig Austria |
James H. Woods, Ph.D. University of Michigan Medical School |
Important Dates
NIDA International Forum
June 14–17, 2013
Online Registration Deadline:
May 6, 2013
FELLOWSHIPS
IAS/NIDA Fellowships
Application Deadline:
February 10, 2013
NIDA International Program Fellowships
Application Deadline:
April 1, 2013
Global Health Program for Fellows and Scholars
Application Deadlines: Vary
GRANTS
Brain Disorders in the Developing World: Research Across the Lifespan
(Non-AIDS)
R01 PAR-11-030and R21 PAR-11-031
Application deadline:
February 14, 2013
MEETINGS
American Association for the Advancement of Science
February 14–18, 2013
Boston, Massachusetts, USA
International Drug Abuse Research Society (IDARS)
April 15–19, 2013
Mexico City, Mexico
2013 International Conference on Global Health: Prevention and Treatment of Substance Abuse and HIV
April 17–19, 2013
Taipei, Taiwan
Yih-Ing Hser, Ph.D.